Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
11/2008
11/27/2008WO2008143343A1 Mutilin derivative having heterocyclic aromatic ring carboxylic acid structure in substituent at 14-position
11/27/2008WO2008143263A1 1-substituted tetrahydroisoquinoline compound
11/27/2008WO2008142528A2 An improved process for preparing nevirapine
11/27/2008WO2008142454A1 Bicyclic aryl and heteroaryl compounds for the treatment of metabolic disorders
11/27/2008WO2008142376A1 Bicyclosulfonyl acid (bcsa) compounds and their use as therapeutic agents
11/27/2008WO2008142006A1 Process for preparing 2-(2-pyridylmethyl)-sulfinyl-1h-benzimidazoles and the intermediate compounds used therein
11/27/2008WO2008141976A1 Diacylglycerol acyltransferase inhibitors
11/27/2008WO2008141843A1 Novel sulphoximine-substituted quinazoline and quinazoline derivatives as kinase inhibitors
11/27/2008WO2008141462A1 Novel case of renin inhibitors
11/27/2008WO2008141385A1 Viral polymerase inhibitors
11/27/2008WO2008107781A3 Triazolquinolonic derivatives with antimycobacterial activity
11/27/2008WO2008101247A3 6 ' substituted indole and indazole derivatives having 5-ht6 receptor affinity
11/27/2008WO2008083367A3 Polycyclic heteroaryl substituted triazoles useful as axl inhibitors
11/27/2008WO2007136790A3 Intracellular kinase inhibitors
11/27/2008WO2007095523A3 Stable dosage formulations of imidazolylalkyl-pyridines
11/27/2008WO2005025498A3 Substituted acetanilides and benzamides for the treatment of asthma and pulmonary inflammation
11/27/2008US20080293940 Amide Derivative and Medicine
11/27/2008US20080293934 Method for Chiral Inversion of (S)-(+)-and (R)-(-)-10,11-Dihydro-10-Hydroxy-5H-Dibenz/B,F/Azepine-5-Carboxamide and Optically Enriched Mixtures Thereof
11/27/2008US20080293778 Arylvinylazacycloalkane Compounds and Methods of Preparation and Use Thereof
11/27/2008US20080293775 Substituted Diphenylethers, -Amines, -Sulfides and -Methanes for the Treatment of Respiratory Disease
11/27/2008US20080293773 Amorphous Esomeprazole Hydrate
11/27/2008US20080293772 Salts of picotamide
11/27/2008US20080293771 Azacyclylbenzamide derivatives as histamine-3 antagonists
11/27/2008US20080293769 Polymorphs of a C-Met/Hgfr Inhibitor
11/27/2008US20080293767 1-Isopropyl-2-Oxo-1,2-Dihydropyridine-3-Carboxamide Derivatives Having 5-Ht4 Receptor Agonistic Activity
11/27/2008US20080293763 Novel nitrogen-containing heteroaryl compounds and methods of use thereof
11/27/2008US20080293745 New amino-alkyl-amide derivatives as CCR3 receptor ligands
11/27/2008US20080293737 Ion channel modulators and methods of use
11/27/2008US20080293736 Compositions, Synthesis, and Methods of Using Quinolinone Based Atypical Antipsychotic Agents
11/27/2008US20080293721 Arylthioacetamide carboxylate derivatives as fkbp inhibitors for the treatment of neurological diseases
11/27/2008US20080293720 Pyridinyl Sulfonamide Modulators of Chemokine Receptors
11/27/2008US20080293718 Novel 2-Amino-Imidazole-4-One Compounds and Their Use in the Manufacture of a Medicament to Be Used in the Treatment of Cognitive Impairment, Alzheimer's Disease, Neurodegeneration and Dementia
11/27/2008US20080293716 Benzamide rho-kinase (ROCK-1) inhibitors; N-(2-phenylethyl)-5-(4-pyridinyl)-2-thiophenecarboxamide
11/27/2008US20080293715 Therapeutic Pyrazolo[3,4-b]Pyridines and Indazoles
11/27/2008US20080293709 Novel 2-Amino-Heterocycles Useful in the Treatment of Abeta-Related Pathologies
11/27/2008US20080293708 Pyrimidine Derivatives
11/27/2008US20080293692 Amidating a succinamic acid with a 3-aminolactam to prepare compounds, such as N1-[1,3-dihydro-1-(3-phenoxybenzyl)-2-oxo-5-(phenyl)-2H-1,4-benzodiazepin-3-yl]-2-(2-methylpropyl)-3-(allyl)-butanediamide
11/27/2008US20080293688 Aminoazacyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligands
11/27/2008US20080293687 Benzamide Compounds
11/27/2008US20080293684 Heterocyclic Acetophenone Potentiators of Metabotropic Glutamate Receptors
11/27/2008US20080293680 Substituted Ethane-1,2-Diamines for the Treatment of Alzheimer's Disease II
11/27/2008US20080293674 Azinyl Imidazoazine and Azinyl Carboxamide
11/27/2008US20080293573 Use as pesticide, microbiocide, or herbicide
11/27/2008US20080292589 Novel heterocyclic substituted pyridine or phenyl compounds with cxcr3 antagonist activity
11/27/2008DE19607203B4 Thermoplastische Harzmasse A thermoplastic resin composition
11/27/2008CA2688057A1 Novel case of renin inhibitors
11/27/2008CA2688008A1 Mutilin derivative having heterocyclic aromatic ring carboxylic acid structure in substituent at 14-position
11/27/2008CA2687958A1 1-substituted tetrahydroisoquinoline compound
11/27/2008CA2687611A1 Novel sulphoximine-substituted quinoline and quinazoline derivatives as kinase inhibitors
11/27/2008CA2687415A1 Bicyclosulfonyl acid (bcsa) compounds and their use as therapeutic agents
11/27/2008CA2687283A1 Quinazolin-oxime derivatives as hsp90 inhibitors
11/27/2008CA2686951A1 Diacylglycerol acyltransferase inhibitors
11/27/2008CA2686016A1 Quinoline derivatives as pi3 kinase inhibitors
11/27/2008CA2685318A1 5-(aminoazacyclyl)-3-sulfonyl-1h-indazoles as 5-hydroxytryptamine-6 ligands for the treatment of cns disorders
11/27/2008CA2685047A1 Process for preparing 2-(2-pyridylmethyl)sulphinyl-1h-benzimidazoles and intermediate compounds used therein
11/26/2008EP1995246A1 Nitrogenated heterocyclic derivative, and pharmaceutical agent comprising the derivative as active ingredient
11/26/2008EP1995243A1 Triazole derivative or salt thereof
11/26/2008EP1995242A1 Novel 1,2,3,4-tetrahydroquinoxaline derivative having glucocorticoid receptor binding activity
11/26/2008EP1995240A1 Quinolone derivative or pharmaceutically acceptable salt thereof
11/26/2008EP1994032A1 Pyrazole derivatives as sigma receptor inhibitors
11/26/2008EP1994030A1 Multi-cyclic compounds and method of use
11/26/2008EP1994028A1 Quinoline derivatives for treating cancer
11/26/2008EP1994027A2 N-formyl hydroxylamine compounds
11/26/2008EP1994026A2 New amines
11/26/2008EP1994024A2 Quinoline derivatives
11/26/2008EP1994023A1 Quinazoline derivatives
11/26/2008EP1994022A2 N-substituted-azacyclylamines as histamine-3 antagonists
11/26/2008EP1994021A2 Quinazoline derivatives as phosphodiesterase 10 inhibitors
11/26/2008EP1994020A2 Substituted quinolones iii
11/26/2008EP1994019A2 Novel piperidin - substituted indoles and their use as ccr-3 modulators
11/26/2008EP1994015A1 Dibenzyl amine derivatives as cetp inhibitors
11/26/2008EP1994011A1 Sulfonyl benzimidazole derivatives
11/26/2008EP1994004A2 1,4-disubstituted 3-cyano-pyridone derivatives and their use as positive allosteric modulators of mglur2-receptors
11/26/2008EP1994003A1 Piperidine derivatives, their process for preparation, their use as therapeutic agents and pharmaceutical compositions containing them .
11/26/2008EP1994002A1 Piperidine derivatives, their process for preparation, their use as therapeutic agents and pharmaceutical compositions containing them
11/26/2008EP1993999A1 Improved prodrugs of cc-1065 analogs
11/26/2008EP1993560A2 Cannabinoid receptor antagonists/inverse agonists useful for treating obesity
11/26/2008EP1993554A2 Urotensin ii receptor antagonists
11/26/2008EP1993551A2 Potassium channel inhibitors
11/26/2008EP1756084B1 Substituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
11/26/2008EP1603913B1 Solvent-free process for the preparation of diketopyrrolopyrrole derivatives
11/26/2008EP1438296B1 1h-imidazole derivatives having cb1 agonistic, cb1 partial agonistic or cb1- antagonistic activity
11/26/2008EP1421070B1 New piperidinyl derivates as modulators of chemokine receptor activity
11/26/2008EP1414455B1 Isoquinoline inhibitors of p38
11/26/2008EP1381382B1 Methods and compositions for the treatment of diseases of the eye
11/26/2008EP1365763B1 Farnesyl protein transferase inhibitor combinations with antiestrogen agents
11/26/2008EP1337517B1 Pyrimidinone derivatives and their use in the treatment of atherosclerosis
11/26/2008EP1330452B1 Pyrazine derivatives as modulators of tyrosine kinases
11/26/2008CN101313223A Mass labels for biomolecules containing a 2,6-dimethyl-piperidin-l-yl methylene or a pyrimidin-2-yl thiomethylene mass marker moiety and a succinimid-oxy-carbonyl reactive functional group
11/26/2008CN101312961A Isoquinoline and benzo[H]isoquinoline derivatives, preparation and therapeutic use thereof as antagonists of the histamine h3 receptor
11/26/2008CN101312960A F,G,H,I and K crystal forms of imatinib mesylate
11/26/2008CN101312955A Process for producing optically active piperazine compound
11/26/2008CN101312954A 4-aminopyrimidine-5-thione-derivatives for the treatment of cancer
11/26/2008CN101312950A Alkyl sulfoxide quinolines as nk-3 receptor ligands
11/26/2008CN101312948A Biaryl substituted heterocycle inhibitors of lta4h for treating inflammation
11/26/2008CN101312726A Hexahydro cyclooctyl pyrazole cannabinoid modulators
11/26/2008CN101312725A Hexahydro cyclooctyl pyrazole cannabinoid modulators
11/26/2008CN101312724A Tetrahydro-indazolyl cannabinoid modulators
11/26/2008CN101312233A Organic electroluminescent device and display apparatus
11/26/2008CN101311174A Vitamin B6 derivates and pharmaceutical use thereof
1 ... 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 ... 1080